Cargando…
COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination
Red cells can be labeled with peptides from the SARS-CoV-2 spike protein (C-19 kodecytes) and used as reagent cells for serologic screening of SARS-CoV-2 antibodies. We evaluated 140 convalescent COVID-19 donors and 275 healthy controls using C19-kodecytes. The analytical performance of the C19-kode...
Autores principales: | Srivastava, Kshitij, West, Kamille A., De Giorgi, Valeria, Holbrook, Michael R., Bovin, Nicolai V., Henry, Stephen M., Flegel, Willy A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653820/ https://www.ncbi.nlm.nih.gov/pubmed/34878316 http://dx.doi.org/10.1128/Spectrum.00830-21 |
Ejemplares similares
-
COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination
por: Flegel, Willy A., et al.
Publicado: (2021) -
COVID‐19 antibody screening with SARS‐CoV‐2 red cell kodecytes using routine serologic diagnostic platforms
por: Nagappan, Radhika, et al.
Publicado: (2021) -
Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals
por: Weinstock, Christof, et al.
Publicado: (2021) -
Two large deletions extending beyond either end of the RHD gene and their red cell phenotypes
por: Srivastava, Kshitij, et al.
Publicado: (2017) -
A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2
por: Kruse, Robert L., et al.
Publicado: (2021)